Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
复制标题
DOI:
10.1016/j.tem.2017.03.005
复制
发表时间:
2017-07
期刊:
影响因子:
--
通讯作者:
Hussain MM
中科院分区:
文献类型:
--
作者:
Iqbal J;Walsh MT;Hammad SM;Hussain MM
Sphingolipids are structurally and functionally diverse molecules with significant physiologic functions and are found associated with cellular membranes and plasma lipoproteins. The cellular and plasma concentrations of sphingolipids are altered in several metabolic disorders and may serve as prognostic and diagnostic markers. Here, we discuss different sphingolipid transport mechanisms and highlight how changes in cellular and plasma sphingolipids levels contribute to cardiovascular disease, obesity, diabetes, insulin resistance and nonalcoholic fatty liver disease. Understanding mechanisms involved in intracellular transport, secretion and extracellular transport may provide novel information that might be amenable to therapeutic targeting in the treatment of various metabolic disorders.